SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-19-027504
Filing Date
2019-05-07
Accepted
2019-05-07 16:15:42
Documents
1
Effectiveness Date
2019-05-07

Document Format Files

Seq Description Document Type Size
1 DEFA14A a19-9457_1defa14a.htm DEFA14A 32414
  Complete submission text file 0001104659-19-027504.txt   33640
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-15006 | Film No.: 19803311
SIC: 2835 In Vitro & In Vivo Diagnostic Substances